Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Reader Login
  Users Online: 988Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2020| January-March  | Volume 11 | Issue 1  
    Online since January 31, 2020

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLE
Compassionate drug use: Current status in India
Yashashri C Shetty, Smita Brahma, PS Manjesh
January-March 2020, 11(1):3-7
DOI:10.4103/picr.PICR_119_18  
  1,232 133 -
ORIGINAL ARTICLES
Factors most influencing antibiotic stewardship program and comparison of prefinal- and final-year undergraduate medical students
Bikash Ranjan Meher, Anand Srinivasan, CS Vighnesh, Biswa Mohan Padhy, Rashmi Ranjan Mohanty
January-March 2020, 11(1):18-23
DOI:10.4103/picr.PICR_162_18  
  699 98 -
A review of clinical studies involving pregnant women registered in the Clinical Trials Registry of India
Sonali Rajiv Karekar, SG Pooja, Padmaja Anil Marathe
January-March 2020, 11(1):8-12
DOI:10.4103/picr.PICR_157_18  
  678 104 -
Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006–2017
Reddy Neha, Viswam Subeesh, Elsa Beulah, Nair Gouri, Eswaran Maheswari
January-March 2020, 11(1):24-30
DOI:10.4103/picr.PICR_140_18  
  638 58 -
Off-label drugs use in neurology outpatient department: A prospective study at a tertiary care teaching hospital
Kunj Arun Gor, Kartik N Shah, Pranav B Joshi, Harsh M Joshi, Devang A Rana, Supriya D Malhotra
January-March 2020, 11(1):31-36
DOI:10.4103/picr.PICR_117_18  
  594 61 -
A comparative study to evaluate quality of data documentation between investigator-initiated and pharmaceutical industry-sponsored studies
Brinal H Figer, Keyur P Sapra, Nithya J Gogtay, Urmila M Thatte
January-March 2020, 11(1):13-17
DOI:10.4103/picr.PICR_122_18  
  471 69 -
EDITORIAL
Embedding good clinical practice into investigator-initiated studies or trials
Sanish Davis
January-March 2020, 11(1):1-2
DOI:10.4103/picr.PICR_2_20  
  207 88 -
ETHICS EDUCATION
New drugs and clinical trials rules 2019: Changes in responsibilities of the ethics committee
Neelu Singh, Nivedita J Madkaikar, Partha M Gokhale, Deven V Parmar
January-March 2020, 11(1):37-43
DOI:10.4103/picr.PICR_208_19  
  82 50 -
READING BETWEEN THE LINES
CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with T2D trial
Baishali Nath, Viraj Ramesh Suvarna
January-March 2020, 11(1):44-46
DOI:10.4103/picr.PICR_157_19  
  71 31 -
STATISTICS
Study designs: Part 5 – Interventional studies (III)
Priya Ranganathan, Rakesh Aggarwal
January-March 2020, 11(1):47-50
DOI:10.4103/picr.PICR_209_19  
  56 45 -
  Feedback 
  Subscribe